$DMRA

$21.96 +$0.70 (3.29%) Close

$DMRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$DMRA Management Team

Dr. Carl Goldfischer

Independent Chairman of the Board

Age 66

Compensation $114.2K USD

Sex Male

Mr. Sherwin Sattarzadeh

Interim Principal Executive Officer

Chief Operating Officer

Age 47

Compensation -

Sex Male

Ms. Lori Firmani

Interim Chief Financial Officer

Age 52

Compensation $561.9K USD

Sex Female

Mr. Matthew Kronmiller

Executive Vice President of Strategy

Chief Business Officer

Age 38

Compensation -

Sex Male

Mr. Garrett Winslow

General Counsel

Corporate Secretary

Age 46

Compensation $897.4K USD

Sex Male

Dr. Becker Hewes

Chief Medical Officer

Age 59

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Carl Goldfischer Independent Chairman of the Board	66	$114.2K USD	Male
Mr. Sherwin Sattarzadeh Interim Principal Executive Officer Chief Operating Officer	47	-	Male
Ms. Lori Firmani Interim Chief Financial Officer	52	$561.9K USD	Female
Mr. Matthew Kronmiller Executive Vice President of Strategy Chief Business Officer	38	-	Male
Mr. Garrett Winslow General Counsel Corporate Secretary	46	$897.4K USD	Male
Dr. Becker Hewes Chief Medical Officer	59	-	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

1 of 2

stated in the proxy; 4 not stated

Average tenure

0.5 years

from year joined

CEO also chairs the board

Peter Harwin

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Michael Landsittel	54	2026 0 years	Not stated	None stated	None stated	Not stated
Cameron Turtle	36	2026 0 years	Not stated	None stated	Spyre Therapeutics, Inc.	Not stated
Christopher Cain, Ph.D.	42	2025 1 year	Not stated	None stated	Viridian Therapeutics, Inc.	$7,099
Peter Harwin Board chair	40	2025 1 year	Independent	None stated	Spyre Therapeutics, Inc., Oruka Therapeutics, Inc.	$6,726
Julianne Bruno	40	2025 1 year	Not stated	Compensation Committee	None stated	$8,594
Jennifer Jarrett CEO	55	2026 0 years	Not independent	None stated	Syndax Pharmaceuticals, Inc.	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$DMRA Management Team

Dr. Carl Goldfischer

Mr. Sherwin Sattarzadeh

Ms. Lori Firmani

Mr. Matthew Kronmiller

Mr. Garrett Winslow

Dr. Becker Hewes

Board of Directors

Related-party transactions

No related-party transactions disclosed